Mylan - 31 Year Stock Split History | MYL

Stock split history for Mylan since 1987. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Mylan Annual Stock Splits
Mylan Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $16.323B $11.908B
Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $63.693B 10.93
Teva Pharmaceutical Industries (TEVA) Israel $21.588B 6.03
Bausch Health Cos (BHC) Canada $8.549B 6.37
Dr Reddy's Laboratories (RDY) India $5.666B 25.31
Supernus Pharmaceuticals (SUPN) United States $2.524B 27.01
Mallinckrodt Public (MNK) United Kingdom $2.267B 3.85
Amphastar Pharmaceuticals (AMPH) United States $0.844B 121.60
Akorn (AKRX) United States $0.828B 0.00
Homology Medicines (FIXX) United States $0.740B 0.00
CymaBay Therapeutics (CBAY) United States $0.605B 0.00
Assembly Biosciences (ASMB) United States $0.589B 0.00
Voyager Therapeutics (VYGR) United States $0.488B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.480B 0.00
Corium (CORI) United States $0.455B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.454B 0.00
Teligent (TLGT) United States $0.181B 0.00
Sol-Gel Technologies (SLGL) Israel $0.121B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.111B 0.00
Aevi Genomic Medicine (GNMX) United States $0.072B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.060B 0.00
Evoke Pharma (EVOK) United States $0.043B 0.00
Acasti Pharma (ACST) Canada $0.037B 0.00
Versartis (ARAV) United States $0.036B 0.00
Agile Therapeutics (AGRX) United States $0.028B 0.00
China Pharma Holdings (CPHI) China $0.015B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.010B 0.00